[Ophthalmic application of minocycline].
D000038:Abscess / Q000188:drug therapy; D000284:Administration, Oral; D000328:Adult; D000368:Aged; D000818:Animals; D001082:Aqueous Humor / Q000378:metabolism; D002648:Child; D003315:Cornea / Q000378:metabolism; D003607:Dacryocystitis / Q000188:drug therapy; D005123:Eye / Q000378:metabolism; D005128:Eye Diseases / Q000188:drug therapy*; D005129:Eye Foreign Bodies / Q000188:drug therapy; D005131:Eye Injuries / Q000188:drug therapy; D005260:Female; D006726:Hordeolum / Q000188:drug therapy; D006801:Humans; D007267:Injections; D008297:Male; D008826:Microbial Sensitivity Tests; D008875:Middle Aged; D011817:Rabbits; D013210:Staphylococcus / Q000187:drug effects; D013752:Tetracycline / Q000009:adverse effects / Q000097:blood / Q000378:metabolism / Q000494:pharmacology / Q000627:therapeutic use*
D013752:Tetracycline